VACHU
Voyager Acquisition Corp Unit
$10.700+0.000 (0.000%)
Real-time Price
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$0.000
High
$0.000
Low
$0.000
Volume
0.00M
Company Fundamentals
Trading Stats
Related News
GlobeNewswire
VERAXA Biotech and Voyager Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-Listed Biopharmaceutical Company Advancing a Pipeline of Next-Generation Cancer Therapies
VERAXA's Novel BiTAC Platform has the Potential to Deliver Multiple Next-Generation Solid Tumor Cancer Therapies, Including Novel Antibody-Drug Conjugate ("ADC") and Bispecific T-cell Engager ("TCE")
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.